Skip to content

Federal Contractor Profile

Novartis Pharmaceuticals Corporation

$66M obligated·89 awards·4 agencies·2 NAICS

Federal Contracts

Showing award actions 101–115 of 115 funded award actions, most recent first.

Contracts with positive obligations
89
Funded award actions shown
115
Obligations shown
$66M
Awarding agencies
4

This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.

Award data as of November 3, 2026. Source: USAspending federal award records.

DateAgencyPIIDNAICSDescriptionAmount
Apr 28, 2020Department of Veterans Affairs249-NETWORK CONTRACT OFFICE 9 (36C249)36C24920N0454325412EMERGENCY TISAGENLECLEUCEL$284K
Apr 6, 2020Department of Veterans Affairs257-NETWORK CONTRACT OFFICE 17 (36C257)36C25720F0196325412KYMRIAH (TISAGEN LECLEUCEL) CANCER MEDICATION$284K
Mar 4, 2020Department of Veterans Affairs245-NETWORK CONTRACT OFFICE 5 (36C245)36C24520F0380325412SIGNIFOR LAR$37K
Feb 26, 2020Department of Veterans Affairs249-NETWORK CONTRACT OFFICE 9 (36C249)36C24920N0346325412EMERGENCY TISAGENLECLEUCEL$284K
Dec 30, 2019Department of Veterans Affairs245-NETWORK CONTRACT OFFICE 5 (36C245)36C24520F0252325412SIGNIFOR 0.6MG$14K
Dec 19, 2019Department of Veterans Affairs249-NETWORK CONTRACT OFFICE 9 (36C249)36C24920N0244325412DRUG TISAGENLECLEUCEL TRADE NAME KYMRIAH FOR CAR-T CELL THEARPY$285K
Oct 18, 2019Department of Veterans Affairs249-NETWORK CONTRACT OFFICE 9 (36C249)36C24920N0173325412DRUG TISAGENLECLEUCEL TRADE NAME: KYMRIAH$285K
Sep 6, 2019Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMAHHSO100201700026C541711ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF$636K
Jul 31, 2019Department of Veterans Affairs242-NETWORK CONTRACT OFFICE 02 (36C242)36C24219F0479325412KYMRIAH$284K
Apr 10, 2018Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMAHHSO100201700026C541711ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF$197K
Jan 18, 2018Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMAHHSO100201700026C541711ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF$697K
Sep 14, 2017Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMAHHSO100201700026C541711ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF$24M
Oct 1, 2016Department of Veterans Affairs247-NETWORK CONTRACT OFFICE 7 (36C247)36C24718K0150325412EXPRESS REPORT: FOR PHARMACY ORDERING OFFICER ORDERS FOR PHARMACEUTICALS FOR FY17$12K
Mar 3, 2016Department of Veterans Affairs688-WASHINGTON DCVA24516F0439325412PHARMACEUTICALS FOR DIRECT PATIENT CARE.$8K
Oct 23, 2015Department of Veterans Affairs258-NETWORK CONTRACT OFFICE 18VA25816J0125325412EMERGENCY PURCHASE OF AFINITOR, CANCER DRUG FOR PHX VA FACILITY.$27K

Get Alerted Before Novartis Pharmaceuticals Corporation's Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start for free